Cargando…
VX‐765 ameliorates renal injury and fibrosis in diabetes by regulating caspase‐1‐mediated pyroptosis and inflammation
INTRODUCTION: As a lytic inflammatory cell death, pyroptosis has been recently described but has not been unequivocally elucidated in diabetic nephropathy (DN). VX‐765 is a safe and effective inhibitor of caspase‐1, that was well tolerated in a phase II clinical trial in patients with epilepsy, but...
Autores principales: | Wen, Si, Deng, Fei, Li, Lulu, Xu, Li, Li, Xin, Fan, Qiuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756311/ https://www.ncbi.nlm.nih.gov/pubmed/34494385 http://dx.doi.org/10.1111/jdi.13660 |
Ejemplares similares
-
VX765, a Specific Caspase-1 Inhibitor, Alleviates Lung Ischemia Reperfusion Injury by Suppressing Endothelial Pyroptosis and Barrier Dysfunction
por: Wu, Siyi, et al.
Publicado: (2021) -
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway
por: Do Carmo, Helison, et al.
Publicado: (2018) -
Effect of VX-765 on the transcriptome profile of mice spinal cords with acute injury
por: Chen, Jing, et al.
Publicado: (2020) -
VX-765 reduces neuroinflammation after spinal cord injury in mice
por: Chen, Jing, et al.
Publicado: (2021) -
VX-765 has a Protective Effect on Mice with Ovarian Injury Caused by Chemotherapy
por: Lee, Pingyin, et al.
Publicado: (2023)